Najah Albadari

Najah Albadari

Pharmaceutical Chemistry, University of Ha'il, Ha'il, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
NANajah Albadari
Najah Albadari
Wei LiWei Li
Wei Li
Survivin, as a member of the inhibitor of apoptosis proteins (IAPs) family, acts as a suppressor of apoptosis and plays a central role in cell division. Survivin has been considered as an important cancer drug target because it is highly expressed in many types of human cancers, while it is effectively absent from terminally differentiated normal tissues. Moreover, survivin is involved in tumor cell resistance to chemotherapy and radiation. Preclinically, downregulation of survivin expression or function reduced tumor growth induced apoptosis and sensitized tumor cells to radiation and chemotherapy in different human tumor models. This review highlights the role of survivin in promoting cellular proliferation and inhibiting apoptosis and summarizes the recent advances in and challenges of developing small-molecule survivin inhibitors.

11 August 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HCHao Chen
Hao Chen
SDShanshan Deng
Shanshan Deng
NANajah Albadari
Najah Albadari
MYMi-Kyung Yun
Mi-Kyung Yun
Sicheng ZhangSicheng Zhang
Sicheng Zhang
Wei LiWei Li
Wei Li